What is the current valuation of the US brucellosis market in 2024?

The US brucellosis market was valued at 138.09 USD Million in 2024. Read More

What is the projected market valuation for the US brucellosis market by 2035?

The projected valuation for the US brucellosis market is 289.81 USD Million by 2035. Read More

What is the expected CAGR for the US brucellosis market during the forecast period 2025 - 2035?

The expected CAGR for the US brucellosis market during the forecast period 2025 - 2035 is 6.97%. Read More

Which companies are the key players in the US brucellosis market?

Key players in the US brucellosis market include Zoetis Inc, Merck & Co Inc, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Heska Corporation, Vetoquinol SA, and Elanco Animal Health. Read More

What are the main segments of the US brucellosis market?

The main segments of the US brucellosis market include species, diagnosis, treatment, and end-user. Read More

What was the market valuation for Brucella abortus in 2024?

The market valuation for Brucella abortus was between 30.0 and 60.0 USD Million in 2024. Read More

How much is the market for antibiotics projected to grow in the treatment segment?

The market for antibiotics in the treatment segment is projected to range from 40.0 to 80.0 USD Million. Read More

What is the valuation range for serological tests in the diagnosis segment?

The valuation range for serological tests in the diagnosis segment was between 20.0 and 40.0 USD Million. Read More

Which end-user segment is expected to have the highest valuation in 2024?

The pharmaceutical & biotechnology companies segment is expected to have the highest valuation, ranging from 50.0 to 100.0 USD Million. Read More

What is the projected growth for the Brucella canis segment by 2035?

The Brucella canis segment is projected to grow, with a valuation range of 15.0 to 30.0 USD Million. Read More

US Brucellosis Market

ID: MRFR/LS/18051-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Brucellosis Market Research Report: By species (Brucella suis, B. abortus, B. melitensis) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Species (USD Million)
  1. 4.1.1 Brucella suis
  2. 4.1.2 Brucella abortus
  3. 4.1.3 Brucella melitensis
  4. 4.1.4 Brucella canis
  5. 4.1.5 others
2. 4.2 Medical Device, BY Diagnosis (USD Million)
  1. 4.2.1 serological tests
  2. 4.2.2 molecular techniques
  3. 4.2.3 bone marrow biopsy
  4. 4.2.4 X-rays
  5. 4.2.5 computerized tomography (CT)
  6. 4.2.6 magnetic resonance imaging (MRI)
  7. 4.2.7 cerebrospinal fluid culture
  8. 4.2.8 echocardiography
  9. 4.2.9 others
3. 4.3 Medical Device, BY Treatment (USD Million)
  1. 4.3.1 antibiotics
  2. 4.3.2 vaccines
  3. 4.3.3 others
4. 4.4 Medical Device, BY End-User (USD Million)
  1. 4.4.1 hospitals & diagnostic centers
  2. 4.4.2 academic institutes
  3. 4.4.3 pharmaceutical & biotechnology companies
  4. 4.4.4 others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Zoetis Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck & Co Inc (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boehringer Ingelheim (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Ceva Santé Animale (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Virbac (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Heska Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Vetoquinol SA (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Elanco Animal Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY SPECIES
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 US MARKET ANALYSIS BY TREATMENT
5. 6.5 US MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY SPECIES, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY SPECIES, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SPECIES, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Species (USD Million, 2025-2035)

Brucella suis
Brucella abortus
Brucella melitensis
Brucella canis
others

Medical Device By Diagnosis (USD Million, 2025-2035)

serological tests
molecular techniques
bone marrow biopsy
X-rays
computerized tomography (CT)
magnetic resonance imaging (MRI)
cerebrospinal fluid culture
echocardiography
others

Medical Device By Treatment (USD Million, 2025-2035)

antibiotics
vaccines
others

Medical Device By End-User (USD Million, 2025-2035)

hospitals & diagnostic centers
academic institutes
pharmaceutical & biotechnology companies
others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”